-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Larixyl acetate
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/4608-49-5.gif)
| Category | Human papillomavirus (HPV) |
| CAS | 4608-49-5 |
| Description | Larixyl acetate is a potent and selective TRPC6 inhibitor with IC50 values of 0.58 μM and 6.83 μM against hTRPC6-YFP and hTRPC3-YFP, respectively. Larixyl acetate prevents HPV and is effective in protecting against traumatic brain injury-induced systemic endothelial dysfunction. |
Product Information
| Synonyms | LARIXYL ACETATE; (13S)-6α-Acetoxylabda-8(17),14-diene-13-ol; (1S,8aβ)-4α-[(S)-3-Methyl-3-hydroxy-4-pentenyl]decahydro-4aα,8,8-trimethyl-3-methylenenaphthalen-1β-ol 1-acetate; (1S,8aβ)-4α-[(S)-3-Methyl-3-hydroxy-4-pentenyl]decahydro-4aα,8,8-trimethyl-3-methy |
| Molecular Weight | 348.52 |
| Molecular Formula | C22H36O3 |
| Canonical SMILES | CC(=O)OC1CC(=C)C(C2(C1C(CCC2)(C)C)C)CCC(C)(C=C)OC(=O)C |
| Melting Point | 82°C |
| Purity | ≥98% (HPLC) |
| Density | 1.00±0.1 g/cm3 (20°C 760 Torr) |
| Solubility | Soluble in ethanol and methan |
| Appearance | Solid powder |
| Storage | Desiccate at -20°C |
| Complexity | 649 |
| Exact Mass | 390.27700969 |
| Index Of Refraction | 1.4826 (589.3 nm, 20°C) |
| PSA | 46.53000 |
| Target | hTRPC6: 0.58 μM (IC50) hTRPC3: 6.83 μM (IC50) HPV |
| XLogP3-AA | 5.7 |
